Ilke Kupeli
Istanbul, 34250, Turkey (Türkiye)
NCT Number: NCT05057455
In this prospective study, we aimed to compare the laboratory and clinical results of cytokine hemadsorption as an immunomodulation therapy in ICU patients diagnosed with sepsis or septic shock.
Looking for future studies?
Notify Me18 year–100 year
All sexes
Observational
Istanbul, 34250, Turkey (Türkiye)
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
the laboratory and clinical results of cytokine hemadsorption as an immunomodulation therapy in ICU patients diagnosed with sepsis or septic shock.
Time frame: 1 YEARS
levels of IL-6
Biruni University
Other
Effectiveness of the Cytokine Hemadsorption on the Clinical Progression and Mortality of Intensive Care Patients With Sepsis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07681362
Behavior, Cardiorespiratory Fitness
Samsun, Turkey (Türkiye)
View Trial DetailsNCT07241741
Body Weight, C-reactive Protein
View Trial DetailsNCT07231731
Arterial Occlusive Diseases, Arteriosclerosis
Osijek, Croatia
View Trial DetailsNCT07001904
Disease Severity, Interleukin-6
Tanta, El-Gharbia, Egypt
View Trial Details